No, my site did not get overrun by the pharmaceutical pushers that like to submit “advice” in the comments section. The title is referring to…
As is a recurring theme on this blog, my readers have led me back from darkness into the light. In response to yesterday’s post, Harry Vartanian pointed…
Update Feb 28, 2019: The allowance rates were in fact probably not this high. I failed basic patent law history as explained here. This week…
If I want a quick (albeit imperfect) overview of how “easy” or “difficult” an examiner is, I generally look at 3 examiner metrics: Total Actions…